Title : The Journey of an EGFR-Mutant Lung Adenocarcinoma through Erlotinib, Osimertinib and ABCP Immunotherapy Regimens: Sensitivity and Resistance.

Pub. Date : 2019 Sep-Dec

PMID : 31762748






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The Journey of an EGFR-Mutant Lung Adenocarcinoma through Erlotinib, Osimertinib and ABCP Immunotherapy Regimens: Sensitivity and Resistance. erlotinib epidermal growth factor receptor Homo sapiens